If ARS is off the table it wouldn't make sense for Pluristem to keep it on their website.

Whatever happened to the BARDA deal?They have had the CNN ARS video posted on their website for well over a year now. Still no results given.

Can't find Pluristem on the agenda. Am I missing something ?

They still have the CNN ARS video as a top story on the Pluristem website. Do you think that after more than a year it is time for an update?

Have to admit, today's PR was a bit vague and ambiguous. Lacking time frames.

The CNN video implied that the DoD study had already started. If that is the case, we should see some results in the near term. My fingers are crossed, how about yours.

It's beyond me why some of you keep your investment in Pluristem. If you are so dissolusioned with the stock and the management, there is simple solution...sell and move on.

Gotta be getting close to seeing some results from the DoD study. We are close to a year since the study was announced.

It appears that the next time Pluristem receives a patent they need to keep it under their hat. It always seems to create a drop in the PPS.

Glad I still have a strong hold on all my shares. Good news could come any time. I'll be locked and loaded when it does.

I still say that the mustard gas study is a good sign that things have gone well in the ARS study.

Anyone have a clue as to when we will get results from the DoD pilot study for ARS? It's been close to a year now that the announcement was made. They still have the CNN video on Pluristem's website. Would be nice to get an update.

For some reason I thought they were using mice in the DoD ARS study.

You can honestly say that an 85% survival rate in irradiated NHP's treated with PLX-R18 is not good news?

Not all were "fluff" stories. However, the current PPS is not a good reflection of all the good news. Hard to figure out.

Correction...Condoleezza.

I was loading a Fox News video with Condoessa Rice playing the piano...when what comes on but an ad from Thermo Fisher Scientific.

My own personal opinion? I have found that both members of Pluristem's upper level management to be extremely knowledgeable about the science end of the company.

You didn't finish my quote. I said "if that is the case". I was only acknowledging his hypothesis.

I'm a Christian man. I have been taught to be kind to everyone.

Are you a shareholder here too? A lemming? The main bright spot I see here is PLX-R18. Good trial results on NHP's. Lots of potential there. I believe the science here can outweigh poor management if that is the case.

Good night blue.

We will have to wait and see if there is more to know next week. And no, this is not happy. I take it that it is intended to be an insult.

My question for Mr. Market is why did psti go up 4% today with no news? Makes no sense.

"The two most powerful warriors are patience and time" - Tolstoy
Stay the course longs. Let the naysayers say what they will.

One thing we can all agree on is that the collaboration was and is an absolute necessity. Storage of a stockpile of PLX-R18 alone is way beyond Pluristem's capacity. Just watch the CNN video and see just one storage container. It's small when you consider that 1000's of doses require storage.

Pluristem is now one step closer to being able to supply stockpiles of PLX-R18 if the DoD requests it. The chances of that happening is beyond me. Any thoughts?

"mutually beneficial partnership" sounds like good news to me

This agreement definitely puts some meat on the bones of Pluristem. It will be interesting to see the terms of the collaboration later!

Will this agreement help with the storage issue associated with stockpiling PLX-R18?

Did this fizzle out or can we expect something tomorrow?

Listen to either of the CEO's and it's easy to see that they know the science behind the product. When their product goes to market they won't be the only ones "lining their pockets",

I'm thankful for a country where we can have an open forum like this one. Keep our servicemen and servicewomen in your prayers.

Nice spike in volume at the EOD.

You see...there is hope here.

Is it just me or is an 85% survival rate of irradiated NHP's something to make one hopeful of future success? Also, the mustard gas study is being conducted by the same DoD that "should" be close to finishing their own ARS study. Seems like something positive must have happened in their ARS study for them to want to test the same indication for mustard gas poisoning. Just a thought.

Can't wrap my head around why you're hanging on to what you perceive to be a sinking ship. Could you expound on that?

Perfect picture. Right on the edge of a big move.

Pluristem is like a boulder sitting on the top of a mountain. It has potential energy. One little nudge (a partnership, approval, etc.) and the potential will become kinetic.

Yes, I have. Just curious as to what you perceive to be the main problem?